Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep ; volume:20 ; number:1 ; day:3 ; month:10 ; year:2023 ; pages:1-12 ; date:12.2023
Virology journal ; 20, Heft 1 (3.10.2023), 1-12, 12.2023
- Urheber
-
Matsiela, Matome Selina
Naicker, Leeann
Khoza, Thandeka
Mokoena, Nobalanda
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-023-02180-2
- URN
-
urn:nbn:de:101:1-2024013114174898749630
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Matsiela, Matome Selina
- Naicker, Leeann
- Khoza, Thandeka
- Mokoena, Nobalanda
- SpringerLink (Online service)
Ähnliche Objekte (12)
Recognizing rift valley fever
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens
Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3
Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya
Rift Valley fever and Brucella spp. in ruminants, Somalia
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
Observations on rift valley fever virus and vaccines in Egypt
Rift valley fever outbreak in Sembabule District, Uganda, December 2020
Immune correlates of protection following Rift Valley fever virus vaccination
Recognizing rift valley fever
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens
Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3
Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya
Rift Valley fever and Brucella spp. in ruminants, Somalia
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
Observations on rift valley fever virus and vaccines in Egypt
Rift valley fever outbreak in Sembabule District, Uganda, December 2020
Immune correlates of protection following Rift Valley fever virus vaccination
Recognizing rift valley fever
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens
Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3
Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya
Rift Valley fever and Brucella spp. in ruminants, Somalia
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
Observations on rift valley fever virus and vaccines in Egypt
Rift valley fever outbreak in Sembabule District, Uganda, December 2020